BIOMAT Database Logo BIOMAT Database Logo

N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists. 1988

L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Department of Organic Pharmaceutical Chemistry, Uppsala Biomedical Center, University of Uppsala, Sweden.

N,N-Dialkylated monophenolic derivatives of trans-2-phenylcyclopropylamine were synthesized and tested for central 5-hydroxytryptamine (5-HT) and dopamine (DA) receptor stimulating activity by use of a biochemical test method in rats. A hydroxy substituent in the 2- or 3-position of the phenyl ring was required for 5-HT-receptor stimulation. N,N-Diethyl or N,N-di-n-propyl substitution gave the most potent 5-HT-receptor agonists. The 4-hydroxy and 3,4-dihydroxy derivatives of trans-2-phenyl-N,N-di-n-propylcyclopropylamine were inactive at central DA and 5-HT receptors. In contrast, the corresponding 3-hydroxy derivative 18 and some of its derivatives weakly affected both DA and NE synthesis. Two of the most potent 5-HT-receptor agonists, trans-2-(2-hydroxyphenyl)-N,N-di-n-propylcyclopropylamine (8) and the 3-hydroxy isomer 18 were resolved into the enantiomers. The 1R,2S enantiomers of 8 and 18 displayed 5-HT activity, while the 1S,2R enantiomers were inactive. Compound (1R,2S)-18, but not (1R,2S)-8, weakly affected rat brain DA and NE synthesis.

UI MeSH Term Description Entries
D008297 Male Males
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011985 Receptors, Serotonin Cell-surface proteins that bind SEROTONIN and trigger intracellular changes which influence the behavior of cells. Several types of serotonin receptors have been recognized which differ in their pharmacology, molecular biology, and mode of action. 5-HT Receptor,5-HT Receptors,5-Hydroxytryptamine Receptor,5-Hydroxytryptamine Receptors,Receptors, Tryptamine,Serotonin Receptor,Serotonin Receptors,Tryptamine Receptor,Tryptamine Receptors,Receptors, 5-HT,Receptors, 5-Hydroxytryptamine,5 HT Receptor,5 HT Receptors,5 Hydroxytryptamine Receptor,5 Hydroxytryptamine Receptors,Receptor, 5-HT,Receptor, 5-Hydroxytryptamine,Receptor, Serotonin,Receptor, Tryptamine,Receptors, 5 HT,Receptors, 5 Hydroxytryptamine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Recent advances in central 5-hydroxytryptamine receptor agonists and antagonists.
January 1986, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Novel 5-hydroxytryptamine 4 (5-HT4) receptor agonists. Synthesis and gastroprokinetic activity of 4-amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamide s.
July 1998, Chemical & pharmaceutical bulletin,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Pivaloyl esters of N,N-dialkylated dopamine congeners. Central dopamine-receptor stimulating activity.
September 1978, Journal of medicinal chemistry,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines.
January 2012, Drug testing and analysis,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents.
July 2006, Journal of medicinal chemistry,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity.
April 1981, Journal of medicinal chemistry,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Effects of 5-hydroxytryptamine and 5-hydroxytryptamine receptor agonists on ion transport across mammalian airway epithelia.
September 1992, Clinical science (London, England : 1979),
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
November 1994, Molecular pharmacology,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation.
February 1975, European journal of pharmacology,
L E Arvidsson, and A M Johansson, and U Hacksell, and J L Nilsson, and K Svensson, and S Hjorth, and T Magnusson, and A Carlsson, and P Lindberg, and B Andersson
N-tetradecylcarbamyl lipopeptides as novel agonists for Toll-like receptor 2.
August 2014, Journal of medicinal chemistry,
Copied contents to your clipboard!